This is most clearly exemplified by the fact that individuals with germline pathogenic mutations in BRCA1 have a massively elevated risk of ovarian cancers of the high-grade serous subtype (HGSOC)37. This evidence concerns the gene BRCA1 and ovarian carcinoma.